Decisions on the introduction of new non-drug health technologies into healthcare are challenging. This article describes the introduction of insulin pump therapy for type 1 diabetes in Alberta, using an Access with Evidence Development (AED) approach. The organization and implementation of the AED, its current status, and lessons learned are described.
Get full access to this article
View all access options for this article.
References
1.
SiebertMClaussLCCarlisleM. Health technology assessment for medical devices in Europe (what must be considered). Int J Technol Assess Health Care. 2002;18(3):733–740.
2.
TaylorRSIgelsiasCP. Assessing the clinical and cost-effectiveness of medical devices and drugs: are they that different?Value Health. 2009;12(4):402–404.
3.
DrummondMGriffinATarriconeR. Economic evaluation for devices and drugs—same or different?Value Health. 2008;12(4):404–406.
4.
FosterNLMottolaKHoffmanJM. Coverage with evidence development: what to consider. JAMA Neurol. 2014;71(4):399–400.
5.
ClaxtonKPalmerSLongworthL. Informing a decision framework for when NICE should recommend the use of health technologies in the context of an appropriately designed programme of evidence development. Health Technol Assess. 2012;16(46):1–323.
6.
CarinoTSheingoldGTunisS. Using clinical trials as a condition of coverage: lessons from the National Emphysema Treatment Trial. Clin Trials. 2004;1(1):108–114.
7.
LevinLGoereeRSikichN. Establishing a continuum from an evidentiary base to policy development for health technologies: the Ontario experience. Int J Technol Assess Health Care. 2007;23(3):299–309.
8.
MenonDMcCabeCJStafinskiTEdlinR. Principles of design of access with evidence development approaches. A consensus statement from the Banff Summit. Pharmacoeconomics. 2010;28(2):109–111.
9.
MenonDStafinskiTNardelliAJacksonTJhamandasJ. Access with evidence development: an approach to introducing promising new technologies into healthcare. Healthc Manage Forum. 2011;24(2):42–48.
10.
BorowskiHZBrehautJHaileyD. Linking evidence from health technology assessments to policy and decision making: the Alberta model. Int J Technol Assess Health Care. 2007;23(2):155–161.
HorsmanJFurlongWFeenyDTorranceG. The Health Utilities Index (HUI®): concepts, measurement properties and applications. Health Qual Life Outcomes. 2003;1:54.
13.
HerdmanMGudexCLloydAJanssenMF. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–1736.
14.
BradleyC. The diabetes treatment satisfaction questionnaire: DTSQ. In: BradleyC, ed. Handbook of Psychology and Diabetes: A Guide to Psychological Measurement in Diabetes Research and Practice. Chur, Switzerland: Harwood Academic Publishers; 1994;111–132.
15.
NovakMGuestC. Application of a multidimensional Care Burden Inventory. Gerontologist. 1989;29(6):798–803.
16.
LangC. ICD Registry: Program Summary. Washington, DC: National Cardiovascular Data Registry; 2009.
